(MedPage Today) — SAN FRANCISCO — Adding hormone therapy to postoperative radiotherapy did not improve overall survival (OS) for most men with prostate cancer, according to a meta-analysis of individual patient data.
Across six randomized…

Read the full article on medpagetoday.com